Proposed Collection; 60-Day Comment Request; Generic Clearance for the Collection of Customer Participation and Performance Management With NIH Programs, Products, and Services (National Institutes of Health), 29681-29682 [2023-09708]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 88 / Monday, May 8, 2023 / Notices
Fax: (301) 594–0899, Email: DGM@
ihs.gov.
AND
U.S. Department of Health and Human
Services, Office of Inspector General,
ATTN: Mandatory Grant Disclosures,
Intake Coordinator, 330 Independence
Avenue SW, Cohen Building, Room
5527, Washington, DC 20201, URL:
https://oig.hhs.gov/fraud/reportfraud/ (Include ‘‘Mandatory Grant
Disclosures’’ in subject line), Fax:
(202) 205–0604 (Include ‘‘Mandatory
Grant Disclosures’’ in subject line) or
Email: MandatoryGranteeDisclosures
@oig.hhs.gov.
Failure to make required disclosures
can result in any of the remedies
described in 45 CFR 75.371 Remedies
for noncompliance, including
suspension or debarment (see 2 CFR
part 180 and 2 CFR part 376).
VII. Agency Contacts
1. Questions on the program matters
may be directed to:
Donna E. Enfield, Public Health
Advisor, Office of Clinical and
Preventative Services, 5600 Fishers
Lane, Rockville, MD 20857, Phone:
(301) 526–6966, Email: IHSCHAP@
ihs.gov.
2. Questions on grants management
and fiscal matters may be directed to:
Indian Health Service, Division of
Grants Management, 5600 Fishers
Lane, Mail Stop: 09E70, Rockville,
MD 20857, Email: DGM@ihs.gov.
3. For technical assistance with
Grants.gov, please contact the
Grants.gov help desk at (800) 518–4726,
or by email at support@grants.gov.
4. For technical assistance with
GrantSolutions, please contact the
GrantSolutions help desk at (866) 577–
0771, or by email at help@
grantsolutions.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
VIII. Other Information
The Public Health Service strongly
encourages all grant, cooperative
agreement, and contract awardees to
provide a smoke-free workplace and
promote the non-use of all tobacco
products. In addition, Public Law 103–
227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities
(or in some cases, any portion of the
facility) in which regular or routine
education, library, day care, health care,
or early childhood development
services are provided to children. This
is consistent with the HHS mission to
VerDate Sep<11>2014
21:48 May 05, 2023
Jkt 259001
protect and advance the physical and
mental health of the American people.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023–09721 Filed 5–5–23; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Development, Risk and
Prevention Study Section.
Date: June 1–2, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anna L Riley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7759, Bethesda, MD 20892, 301–435–
2889, rileyann@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Addiction Risks and Mechanisms Study
Section.
Date: June 5–6, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, (301) 496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Arthritis, Connective Tissue and Skin Study
Section.
Date: June 6–7, 2023.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
29681
Time: 8:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Washington DC/
Georgetown, 2201 M. Street NW,
Washington, DC 20037.
Contact Person: Robert Gersch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 867–5309, robert.gersch@
nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Analytics and Statistics for Population
Research Panel B Study Section.
Date: June 6–7, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Campbell
Chambers, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496–5693,
jessica.chambers@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 2, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09702 Filed 5–5–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Generic Clearance for the
Collection of Customer Participation
and Performance Management With
NIH Programs, Products, and Services
(National Institutes of Health)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide an
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, National
Cancer Institute (NCI) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
SUMMARY:
E:\FR\FM\08MYN1.SGM
08MYN1
29682
Federal Register / Vol. 88, No. 88 / Monday, May 8, 2023 / Notices
of having their full effect if received
within 60 days of the date of this
publication.
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Diane Kreinbrink, Program
Manager, Office of Management Policy
and Compliance, National Cancer
Institute, 9609 Medical Center Drive,
Room 2W446, Bethesda, Maryland,
20892 or call non-toll-free number (240)
276–7283 or email your request,
including your address to:
diane.kreinbrink@nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
FOR FURTHER INFORMATION CONTACT:
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public, and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
SUPPLEMENTARY INFORMATION:
outcome metrics where appropriate and
applicable. This input should provide
meaningful information that can be used
to identify strengths and areas that need
improvement. Reports developed from
the review or evaluation may be
presented by the IC Director to the IC’s
Advisory Council or Board, to other IC
or NIH leadership (such as the Deputy
Director for Intramural Research and the
NIH Director), or to program
participants or the broader public. Such
reports may include recommendations
and proposed actions to address areas
for improvement. In public or broadly
shared reports, any sensitive
information in the reviews or
evaluations will be summarized and
presented in aggregate.
This clearance will allow direct
assessment and measurement of the
customer/respondent base for
participation in and satisfaction with
NIH programs, products, and services.
The clearance will also enable offices to
assess participants’ experience and
accomplishments during or since
participation and their preferences for
existing and future programming,
products, and services. The information
collected using these tools informs and
supports budgeting, program
management and design, program
planning, results reporting, information
dissemination, and outreach initiatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
3,375.
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Generic
Clearance for the Collection of Customer
Participation and Performance
Management with NIH Programs,
Products, and Services (NIH), 0925–
XXXX: Expiration Date XX/XX/XXXX,
NEW, National Institutes of Health
(NIH).
Need and Use of Information
Collection: Evaluating the effectiveness
of leadership, programs, and services is
essential for the vitality of any
institution. Leadership review at NIH
focuses on the productivity of the IC,
management of resources and budget
allocations, training activities, and
influence on dimensions of diversity,
inclusion, promotion of investigators
and staff (including NIH Equity
Committee (NEC) reports), and positive
workforce culture.
Program and service reviews may
focus on operational performance;
outputs, outcomes, and impacts; policy
compliance, stewardship, diversity,
equity, and inclusion. Both types of
reviews and evaluations may solicit
input from IC staff and leadership (IC
Director, Deputy Director, E.O.) and
relevant program participants and
stakeholders about the program’s
effectiveness, leader, or process. They
may include comparisons with other ICs
or programs, external benchmarks, and
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Individuals, Households, Private Sector, State
Government, Local Government, Tribal Government, or Federal Government.
ddrumheller on DSK120RN23PROD with NOTICES1
Totals .............................................................
Dated: May 3, 2023.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2023–09708 Filed 5–5–23; 8:45 am]
BILLING CODE 4140–01–P
Number of
respondents
Form name
Performance Measurement.
21:48 May 05, 2023
Jkt 259001
Total burden
hour
500
1
30/60
250
Interviews .....................
Program Reviews .........
Surveys .........................
Focus Groups ...............
1,000
500
5,000
500
1
1
1
1
1
45/60
15/60
1
1,000
375
1,250
500
.......................................
........................
7,500
........................
3,375
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of
responses per
respondent
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
E:\FR\FM\08MYN1.SGM
08MYN1
]]>Agencies
[Federal Register Volume 88, Number 88 (Monday, May 8, 2023)]
[Notices]
[Pages 29681-29682]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Generic Clearance
for the Collection of Customer Participation and Performance Management
With NIH Programs, Products, and Services (National Institutes of
Health)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide an opportunity for public comment on proposed
data collection projects, the National Institutes of Health, National
Cancer Institute (NCI) will publish periodic summaries of proposed
projects to be submitted to the Office of Management and Budget (OMB)
for review and approval.
DATES: Comments regarding this information collection are best assured
[[Page 29682]]
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Diane
Kreinbrink, Program Manager, Office of Management Policy and
Compliance, National Cancer Institute, 9609 Medical Center Drive, Room
2W446, Bethesda, Maryland, 20892 or call non-toll-free number (240)
276-7283 or email your request, including your address to:
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written comments and/or suggestions
from the public, and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: Generic Clearance for the Collection of
Customer Participation and Performance Management with NIH Programs,
Products, and Services (NIH), 0925-XXXX: Expiration Date XX/XX/XXXX,
NEW, National Institutes of Health (NIH).
Need and Use of Information Collection: Evaluating the
effectiveness of leadership, programs, and services is essential for
the vitality of any institution. Leadership review at NIH focuses on
the productivity of the IC, management of resources and budget
allocations, training activities, and influence on dimensions of
diversity, inclusion, promotion of investigators and staff (including
NIH Equity Committee (NEC) reports), and positive workforce culture.
Program and service reviews may focus on operational performance;
outputs, outcomes, and impacts; policy compliance, stewardship,
diversity, equity, and inclusion. Both types of reviews and evaluations
may solicit input from IC staff and leadership (IC Director, Deputy
Director, E.O.) and relevant program participants and stakeholders
about the program's effectiveness, leader, or process. They may include
comparisons with other ICs or programs, external benchmarks, and
outcome metrics where appropriate and applicable. This input should
provide meaningful information that can be used to identify strengths
and areas that need improvement. Reports developed from the review or
evaluation may be presented by the IC Director to the IC's Advisory
Council or Board, to other IC or NIH leadership (such as the Deputy
Director for Intramural Research and the NIH Director), or to program
participants or the broader public. Such reports may include
recommendations and proposed actions to address areas for improvement.
In public or broadly shared reports, any sensitive information in the
reviews or evaluations will be summarized and presented in aggregate.
This clearance will allow direct assessment and measurement of the
customer/respondent base for participation in and satisfaction with NIH
programs, products, and services. The clearance will also enable
offices to assess participants' experience and accomplishments during
or since participation and their preferences for existing and future
programming, products, and services. The information collected using
these tools informs and supports budgeting, program management and
design, program planning, results reporting, information dissemination,
and outreach initiatives.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 3,375.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hour
----------------------------------------------------------------------------------------------------------------
Individuals, Households, Performance 500 1 30/60 250
Private Sector, State Measurement.
Government, Local Government,
Tribal Government, or Federal
Government.
Interviews...... 1,000 1 1 1,000
Program Reviews. 500 1 45/60 375
Surveys......... 5,000 1 15/60 1,250
Focus Groups.... 500 1 1 500
---------------------------------------------------------------
Totals.................... ................ .............. 7,500 .............. 3,375
----------------------------------------------------------------------------------------------------------------
Dated: May 3, 2023.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer Institute, National
Institutes of Health.
[FR Doc. 2023-09708 Filed 5-5-23; 8:45 am]
BILLING CODE 4140-01-P
